Testing cosmetics for skin compatibility
Epicutaneous Testing of Cosmetic Products to Determine Skin Compatibility
This study is testing new and reformulated cosmetics on people's skin to see if they cause any irritation or allergic reactions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Trial ID | NCT03024671 on ClinicalTrials.gov |
What this trial studies
This study evaluates the skin compatibility of cosmetic products, both new and reformulated, by conducting dermatological patch tests. These tests are essential for identifying potential irritants and allergens in cosmetics that could cause dermatitis or allergic reactions. Participants will undergo patch testing to assess their skin's reaction to various cosmetic substances. The goal is to enhance safety and reduce adverse skin reactions associated with cosmetic use.
Who should consider this trial
Good fit: Ideal candidates include men and women over 18 who are undergoing diagnostic patch tests for skin diseases.
Not a fit: Patients with acute skin inflammation or those on certain medications that affect skin response may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to safer cosmetic products and reduce the incidence of dermatitis and allergic reactions in consumers.
How similar studies have performed: Previous studies have successfully utilized patch testing to evaluate skin compatibility of cosmetics, indicating a proven methodology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women older than 18 years old * Persons undergoing a diagnostic patch test for reason of a skin disease * Signed written informed consent Exclusion Criteria: * Acute skin inflammation and eczema on the back * Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of the back within the last 4 weeks * Topical corticosteroids used on the back within the last two weeks
Where this trial is running
Bern
- Inselspital Bern — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Dagmar Simon, MD — Dept. of Dermatology, Inselspital
- Study coordinator: Dagmar Simon, MD
- Email: dagmar.simon@insel.ch
- Phone: +41 31 632 2278
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.